153 related articles for article (PubMed ID: 38599663)
21. The dynamic of non-communicable disease control policy in Indonesia.
Christiani Y; Dugdale P; Tavener M; Byles JE
Aust Health Rev; 2017 May; 41(2):207-213. PubMed ID: 27209156
[TBL] [Abstract][Full Text] [Related]
22. Investing in non-communicable diseases: an estimation of the return on investment for prevention and treatment services.
Bertram MY; Sweeny K; Lauer JA; Chisholm D; Sheehan P; Rasmussen B; Upreti SR; Dixit LP; George K; Deane S
Lancet; 2018 May; 391(10134):2071-2078. PubMed ID: 29627159
[TBL] [Abstract][Full Text] [Related]
23. International investment liberalization, transnational corporations and NCD prevention policy non-decisions: a realist review on the political economy of tobacco, alcohol and ultra-processed food.
Milsom P; Smith R; Baker P; Walls H
Global Health; 2021 Nov; 17(1):134. PubMed ID: 34819083
[TBL] [Abstract][Full Text] [Related]
24. Implementation factors of non-communicable disease policies and programmes for children and youth in low-income and middle-income countries: a systematic review.
Nguyen GT; Gauvreau C; Mansuri N; Wight L; Wong B; Neposlan J; Petricca K; Denburg A
BMJ Paediatr Open; 2024 Jun; 8(1):. PubMed ID: 38830723
[TBL] [Abstract][Full Text] [Related]
25. Next Steps for Elevating Health on Trade and Investment Policy Agendas Comment on "How Neoliberalism Is Shaping the Supply of Unhealthy Commodities and What This Means for NCD Prevention".
Townsend B
Int J Health Policy Manag; 2020 Jul; 9(7):312-314. PubMed ID: 32613803
[TBL] [Abstract][Full Text] [Related]
26. Financing national non-communicable disease responses.
Allen LN
Glob Health Action; 2017; 10(1):1326687. PubMed ID: 28604238
[TBL] [Abstract][Full Text] [Related]
27. A qualitative study of governance of evolving response to non-communicable diseases in low-and middle- income countries: current status, risks and options.
Rani M; Nusrat S; Hawken LH
BMC Public Health; 2012 Oct; 12():877. PubMed ID: 23067232
[TBL] [Abstract][Full Text] [Related]
28. Policies for type 2 diabetes and non-communicable disease management during the COVID-19 pandemic in Kenya and Tanzania: a desk review and views of decision-makers.
Mohamed SF; Kisia L; Mashiashi I; Mair F; Wisdom JP; Bunn C; Gray C; Kibe PM; Sanya RE; Karugu CH; Mtenga SM; Binyaruka P; Asiki G
BMJ Open; 2024 Mar; 14(3):e073261. PubMed ID: 38531573
[TBL] [Abstract][Full Text] [Related]
29. Political priority and pathways to scale-up of childhood cancer care in five nations.
Denburg AE; Ramirez A; Pavuluri S; McCann E; Shah S; Alcasabas T; Antillon F; Arora R; Fuentes-Alabi S; Renner L; Lam C; Friedrich P; Maser B; Force L; Galindo CR; Atun R
PLoS One; 2019; 14(8):e0221292. PubMed ID: 31425526
[TBL] [Abstract][Full Text] [Related]
30. Non-communicable disease (NCD) corners in public sector health facilities in Bangladesh: a qualitative study assessing challenges and opportunities for improving NCD services at the primary healthcare level.
Rawal LB; Kanda K; Biswas T; Tanim MI; Poudel P; Renzaho AMN; Abdullah AS; Shariful Islam SM; Ahmed SM
BMJ Open; 2019 Oct; 9(10):e029562. PubMed ID: 31594874
[TBL] [Abstract][Full Text] [Related]
31. The case for investing in the prevention and control of non-communicable diseases in the six countries of the Gulf Cooperation Council: an economic evaluation.
Elmusharaf K; Grafton D; Jung JS; Roberts E; Al-Farsi Y; Al Nooh AA; Bin Belaila B; ElShamy A; Al-Zuabi H; Al Mutawa KA; Alraisi S; Al Lawat N; Gharbal A; Alomary S; Kulikov A; Pourghazian N; Slama S; Tarlton D; Banatvala N
BMJ Glob Health; 2022 Jun; 7(6):. PubMed ID: 35649631
[TBL] [Abstract][Full Text] [Related]
32. Policy analysis of nutrition stewardship for prevention and control of Non-communicable diseases in Iran.
Amerzadeh M; Takian A; Pouraram H; Sari AA; Ostovar A
BMC Health Serv Res; 2023 Jan; 23(1):79. PubMed ID: 36694184
[TBL] [Abstract][Full Text] [Related]
33. Community health workers for non-communicable diseases prevention and control in Bangladesh: a qualitative study.
Rawal L; Jubayer S; Choudhury SR; Islam SMS; Abdullah AS
Glob Health Res Policy; 2020 Dec; 6(1):1. PubMed ID: 33407942
[TBL] [Abstract][Full Text] [Related]
34. What is the NCD service capacity and disruptions due to COVID-19? Results from the WHO non-communicable disease country capacity survey in the Americas region.
Luciani S; Caixeta R; Chavez C; Ondarsuhu D; Hennis A
BMJ Open; 2023 Mar; 13(3):e070085. PubMed ID: 36863746
[TBL] [Abstract][Full Text] [Related]
35. Use of social impact bonds in financing health systems responses to non-communicable diseases: scoping review.
Hulse ESG; Atun R; McPake B; Lee JT
BMJ Glob Health; 2021 Mar; 6(3):. PubMed ID: 33674267
[TBL] [Abstract][Full Text] [Related]
36. The Case for Integrating Health Systems to Manage Noncommunicable and Infectious Diseases in Low- and Middle-Income Countries: Lessons Learned From Zambia.
Richter P; Aslam M; Kostova D; Lasu AAR; Vliet GV; Courtney LP; Chisenga T
Health Secur; 2022; 20(4):286-297. PubMed ID: 35904943
[TBL] [Abstract][Full Text] [Related]
37. Identifying opportunities to engage communities with social mobilisation activities to tackle NCDs in El Salvador in the context of the global COVID-19 pandemic.
Caperon L; Arakelyan S; Innocenti C; Ager A
Int J Equity Health; 2021 Oct; 20(1):222. PubMed ID: 34627271
[TBL] [Abstract][Full Text] [Related]
38. The investment case as a mechanism for addressing the NCD burden: Evaluating the NCD institutional context in Jamaica, and the return on investment of select interventions.
Hutchinson B; Small R; Acquah K; Sandoval R; Nugent R; Davidson T; Belausteguigoitia DI; Banatvala N; Webb D; Tarlton D; Kulikov A; Prieto E; Santi K
PLoS One; 2019; 14(10):e0223412. PubMed ID: 31584979
[TBL] [Abstract][Full Text] [Related]
39. Non-communicable Diseases Week: Best Practices in Addressing the NCDs Burden from Tanzania.
Njiro BJ; Ngowi JE; Ndumwa HP; Amani D; Munishi C; Mloka D; Balandya E; Rugajo P; Kessy AT; Ubuguyu O; Salum B; Kamuhabwa A; Ramaiya K; Sunguya BF; Mboya EA; Kikula AI; Kitambala E; Kiologwe J; Kengia JT; Kapologwe N
Ann Glob Health; 2023; 89(1):89. PubMed ID: 38107601
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
